Antianginal drug therapy for silent myocardial ischemia
- 31 July 1987
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 114 (1) , 140-147
- https://doi.org/10.1016/0002-8703(87)90317-6
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Mechanisms and therapy of silent myocardial ischemia: The effect of transdermal nitroglycerinAmerican Heart Journal, 1986
- Silent Ischemia as a Marker for Early Unfavorable Outcomes in Patients with Unstable AnginaNew England Journal of Medicine, 1986
- Mechanisms and therapy of silent myocardial ischemia and the effect of transdermal nitroglycerinThe American Journal of Cardiology, 1985
- Rationale for the choice of calcium antagonists in chronic stable angina: An objective double-blind placebo-controlled comparison of niffedipine and verapamilThe American Journal of Cardiology, 1982
- Calcium channel blockade as primary therapy for stable angina pectoris: A double-blind placebo-controlled comparison of verapamil and propranololThe American Journal of Cardiology, 1982
- Verapamil versus propranolol for angina at restThe American Journal of Cardiology, 1982
- Verapamil therapy for Prinzmetal's variant angina: Comparison with placebo and nifedipineThe American Journal of Cardiology, 1982
- Failure of thromboxane A2 blockade to prevent attacks of vasospastic angina.Circulation, 1982
- A Controlled Trial of Verapamil for Prinzmetal's Variant AnginaNew England Journal of Medicine, 1981
- Transient asymptomatic S-T segment depression during daily activityThe American Journal of Cardiology, 1977